在新的ESC指导方针中和超越ESC指导方针中的mexiletine的指示
Mate Vamos1, Elod-Janos Zsigmond2,3, Stefan H Hohnloser4
1Cardiac Electrophysiology Division, Department of Internal Medicine, University of Szeged, Szeged, Hungary.
作为通道阻塞剂的梅克西莱丁,通过缩短作用潜力的持续时间,为其他抗节律药提供了更安全的替代品. 推给LQT3患者使用,可以稳定耐火性心室节律失常.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
背景情况:
- 梅克西莱丁是一种IB类的通道阻塞剂,具有独特的作用潜力持续时间.
- 与IA类或IC类药物不同,它缩短了潜在的作用时间,减少了前节律失常的风险.
研究的目的:
- 审查mexiletine在控制心律失常方面的作用.
- 在最近的欧洲指南中突出其更新的建议.
主要方法:
- 审查现有的文献和指导方针.
- 分析梅克西莱丁的药理性质和临床应用.
主要成果:
- 梅克西莱丁是LQT3患者的一线基因型特异性治疗.
- 它在稳定耐火性心室动脉节律失常症和电风暴方面表现有前途,即使与其他疗法相结合.
结论:
- 梅克西莱丁的安全性使其成为一种有价值的抗心律失常药.
- 它在特定患者群体和耐火性疾病中的有效性值得考虑.
更多相关视频
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Electroconvulsive Therapy
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
